Low dose Emodin induces tumor senescence for boosting breast cancer chemotherapy via silencing NRARP
Open Access
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 505 (4) , 973-978
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of Youth Science (81602549)
This publication has 20 references indexed in Scilit:
- Emodin induces apoptosis of human breast cancer cells by modulating the expression of apoptosis-related genesOncology Letters, 2015
- Inside and out: the activities of senescence in cancerNature Reviews Cancer, 2014
- The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in MelanomaClinical Cancer Research, 2013
- Pro-senescence therapy for cancer treatmentNature Reviews Cancer, 2011
- Four faces of cellular senescenceJournal of Cell Biology, 2011
- The essence of senescence: Figure 1.Genes & Development, 2010
- Nrarp Coordinates Endothelial Notch and Wnt Signaling to Control Vessel Density in AngiogenesisDevelopmental Cell, 2009
- Anti‐cancer properties of anthraquinones from rhubarbMedicinal Research Reviews, 2006
- The Nrarp Gene Encodes an Ankyrin-Repeat Protein That Is Transcriptionally Regulated by the Notch Signaling PathwayDevelopmental Biology, 2001
- Nrarp is a novel intracellular component of the Notch signaling pathwayGenes & Development, 2001